This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MDRP 2022 — Medicaid Drug Rebate Program Summit
Delivered as a Hybrid Event October 11-13th, 2022
In-Person October 11-13Chicago, IL

Constance Wilkinson
Board of Directors, Member of the Firm at Epstein Becker Green


Connie Wilkinson concentrates her practice on pricing and reimbursement policy, commercial pricing, federal health care and health benefits program issues, and contracting strategies—including health care fraud and abuse considerations—for the pharmaceutical, medical devices and products, and biotechnology industries. Based in the Washington, DC, office, she also serves as a member of the firm’s Board of Directors.

Connie regularly:

  • Advises direct and indirect providers in the health care industry regarding pharmaceutical pricing and program compliance under Medicare Parts B and D, the Medicaid Drug Rebate Program, the 340B Drug Discount Program, the Veterans Health Care Act/Federal Supply Schedule Program, and the DoD TRICARE program
  • Conducts due diligence and internal reviews, performs and responds to fraud and abuse investigations, prepares and negotiates voluntary disclosures and restatements, and assists in implementing Corporate Integrity Agreements, including providing counsel regarding reviews conducted by Independent Review Organizations
  • Develops and reviews corporate compliance programs for federal contractors and for direct and indirect providers of health care services, including manufacturers of drugs, devices, and biologicals

Agenda Sessions

  • Fireside Chat and Live Q&A with a Select Group of Speakers and Panelists from the Conference


Speakers at this event